Literature DB >> 22228587

Circulating microRNAs as biomarkers: a new frontier in diagnostics.

Clifford J Steer, Subbaya Subramanian.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22228587     DOI： 10.1002/lt.23377

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  12 in total

Review 1.  MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases.

Authors:  Wu Xiaoyan; Eva Maria Arriero Pais; Li Lan; Chen Jingrui; Miao Lin; Patrick Asare Fordjour; Fan Guanwei
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

Review 2.  Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers.

Authors:  Liang Wei; Xue Gong; Olivia M Martinez; Sheri M Krams
Journal:  Transpl Immunol       Date:  2013-08-31       Impact factor: 1.708

Review 3.  Hypothermic Oxygenated Liver Perfusion: Basic Mechanisms and Clinical Application.

Authors:  A Schlegel; P Kron; P Dutkowski
Journal:  Curr Transplant Rep       Date:  2015

4.  Identification and characterization of novel serum microRNA candidates from deep sequencing in cervical cancer patients.

Authors:  Li Juan; Hong-li Tong; Pengjun Zhang; Guanghong Guo; Zi Wang; Xinyu Wen; Zhennan Dong; Ya-ping Tian
Journal:  Sci Rep       Date:  2014-09-03       Impact factor: 4.379

5.  Serum microRNAs as potential biomarkers of primary biliary cirrhosis.

Authors:  Youwen Tan; Tengli Pan; Yun Ye; Guohong Ge; Li Chen; Danfeng Wen; Shengqiang Zou
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

6.  A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles.

Authors:  Jing Guo; Rui Meng; Zhongyuan Yin; Pengcheng Li; Rui Zhou; Sheng Zhang; Xiaorong Dong; Li Liu; Gang Wu
Journal:  Mol Med Rep       Date:  2016-04-13       Impact factor: 2.952

Review 7.  An emerging role for microRNAs in NF1 tumorigenesis.

Authors:  Ashni Sedani; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2012-11-17       Impact factor: 4.639

8.  Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival.

Authors:  Serena Lucotti; Giuseppe Rainaldi; Monica Evangelista; Milena Rizzo
Journal:  Mol Cancer       Date:  2013-06-05       Impact factor: 27.401

Review 9.  Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation.

Authors:  Reena V Kartha; Subbaya Subramanian
Journal:  Front Genet       Date:  2014-01-30       Impact factor: 4.599

Review 10.  MicroRNAs as Biomarkers in Cancer.

Authors:  Kamini Sundarbose; Reena V Kartha; Subbaya Subramanian
Journal:  Diagnostics (Basel)       Date:  2013-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.